Arjuna Capital Vertex Pharmaceuticals Inc Transaction History

Arjuna Capital

$365 Million
Q2 2024

A detailed history of Arjuna Capital transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Arjuna Capital holds 6,007 shares of VRTX stock, worth $2.81 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

6,007

Previous 5,957 0.84%

Holding current value

$2.81 Million

Previous $2.49 Million 13.05%

% of portfolio

0.77%

Previous 0.72%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$392.81 - $485.53 $19,640 - $24,276	50 Added 0.84%	6,007 $2.82 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $545,896 - $597,301	1,339 Added 29.0%	5,957 $2.49 Million
Q4 2023 Feb 08, 2024	BUY	$343.0 - $410.68 $83,349 - $99,795	243 Added 5.55%	4,618 $1.88 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $9,807 - $10,511	29 Added 0.67%	4,375 $1.52 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $6,917 - $7,742	-22 Reduced 0.5%	4,346 $1.53 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $869,232 - $991,593	-3,069 Reduced 41.27%	4,368 $1.38 Million
Q4 2022 Feb 06, 2023	BUY	$285.76 - $321.48 $69,439 - $78,119	243 Added 3.38%	7,437 $2.15 Million
Q3 2022 Nov 01, 2022	BUY	$273.83 - $305.53 $1.97 Million - $2.2 Million	7,194 New	7,194 $2.08 Million
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $859,298 - $1.15 Million	-4,151 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $14,060 - $16,670	55 Added 1.34%	4,151 $1.13 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $923,566 - $1.21 Million	4,096 New	4,096 $1.19 Million
Q3 2019 Nov 06, 2019	SELL	$166.23 - $187.09 $368,698 - $414,965	-2,218 Closed	0 $0
Q2 2019 Aug 21, 2019	BUY	$164.61 - $190.37 $8,395 - $9,708	51 Added 2.35%	2,218 $406,000
Q2 2019 Aug 08, 2019	BUY	$164.61 - $190.37 $34,074 - $39,406	207 Added 10.56%	2,167 $397,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $23,085 - $27,452	141 Added 7.75%	1,960 $361,000
Q4 2018 Jan 31, 2019	BUY	$151.91 - $192.21 $1,822 - $2,306	12 Added 0.66%	1,819 $302,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $670 - $770	-4 Reduced 0.22%	1,807 $349,000
Q2 2018 Aug 01, 2018	BUY	$145.72 - $169.96 $263,898 - $307,797	1,811 New	1,811 $308,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

News

Stay updated on Arjuna Capital with notifications on news.

Account